Coenzyme Q10 Supplementation in Clinical Medicine

  • Anna Gvozdjáková
  • Anna Hlavatá
  • Jarmila Kucharská
  • Patrik Palacka
  • Ján Murín

Coenzyme Q10 supplementary therapy in patients is based on its antioxidant and reenergization effects. CoQ10 has been successfully used in clinical medicine as a supplementary therapy in several diseases: in patients with mitochondrial neuromuscular diseases, neurodegenerative diseases (Parkinson’s, dementias), cardiovascular diseases (congestive heart failure, cardiomyopathy), statins therapy, chronic fatique syndrom, nephropathy, cancer –breast treatment, chemotheraphy amelioration, diabetes mellitus, bronchial asthma, infertile men, sports medicine, stress and ageing. Bioavailability, dosage and duration of CoQ10 treatment are important factors for human tissue uptake and beneficial effect of administered CoQ10.

Keywords

Glutathione Corticosteroid Dementia Neuropathy Pyruvate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gvozdjáková A, Kucharská J, Hlavatá A, Braunová Z, Reichrtová E, Kajglová A, Kapellerová A (2000) Effect of coenzyme Q10 in children with metabolic diseases. J Am Coll Nutr 19(5): Abstract 117, p 704. The American College of Nutrition’s 41st Annual Meeting, Las Vegas, USA, 12–15 October 2000 (Prize award)Google Scholar

References

  1. 1.
    Gazdíková K, Gvozdjáková A, Kucharská J, Spustová V, Braunová Z, Dzúrik R (2000) Malondialdehyde and selected antioxidant plasma levels in conservatively treated patients with kidney diseases. BMJ 101:490–494Google Scholar
  2. 2.
    Gazdíková K, Gvozdjáková A, Kucharská J, Spustová V, Braunová Z, Dzúrik R (2001) Effect of coenzyme Q10 in patients with kidney disease. Čas Lek Česk 140:307–310 (in Slovak)PubMedGoogle Scholar
  3. 3.
    Gazdíková K, Gvozdjáková A, Kucharská J, Spustová V, Braunová Z, Dzúrik R (2001) Oxidative stress and plasma concentrations of coenzyme Q10, alpha-tocopherol, and beta-carotene in patients widh a mild to moderate decrease of kidney function. Nephron 88(3):285PubMedCrossRefGoogle Scholar
  4. 4.
    Gvozdjáková A (2000) Coenzyme Q10 (experimental study). Effects of hydrosoluble, liposoluble and reduced coenzyme Q10 forms in aged rats. Tishcon Corp. USA: Project, 2000, Part 6, Kidney Mitochondria: P6/4–P17 tables and figuresGoogle Scholar
  5. 5.
    Gvozdjáková A, Gazdíková K, Kucharská J, Spustová V, Braunová Z, Dzúrik R (2000) The effect of coenzyme Q10 in patients with nephropathies. J Am Coll Nutr 19(5):708. American College of Nutrition, 41st Annual Meeting, Las Vegas, 12–15 October 2000, Abstract 132Google Scholar
  6. 6.
    Gvozdjáková A., Gazdíková K, Kucharská J, Spustová V, Braunová Z, Dzúrik R (2000) Deficit of coenzyme Q10 in patients with nephropathies and beneficial effect of supplementary therapy with coenzyme Q10. The Second Conference of the International Coenzyme Q 10 Association, Frankfurt, Germany, 2000, December 1–4, abstract book pp 111–112Google Scholar
  7. 7.
    Lippa S, Colacicco L, Calla C, Gozzo ML, Ciccariello M, Angelitti AG (1994) Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patients. Mol Aspects Med 15 Supplement:213–219CrossRefGoogle Scholar

References

  1. 1.
    Gazdík F, Gvozdjáková A, Nádvorníková R, Repická L, Jahnová J, Kucharská J, Pijak MR, Gazdíková K (2002) Decreased levels of coenzyme Q10 in patients with bronchial asthma. Allergy 57:811–814PubMedCrossRefGoogle Scholar
  2. 2.
    Gvozdjáková A, Kucharská J, Bartkovjaková M, Gazdíková K, Gazdík F (2005a) Coenzyme Q10 supplementation reduces corticosteroid dosage in patients with asthma bronchiale. Fourth Conference of the International Coenzyme Q 10 Association, Los Angeles, 2005, Abstract book pp 108–109Google Scholar
  3. 3.
    Gvozdjáková A, Kucharská J, Bartkovjaková M, Gazdíková K, Gazdík F (2005b) Coenzyme Q10 supplementation reduces corticosteroid dosage in patients with asthma bronchiale. BioFactors 25:235–240PubMedCrossRefGoogle Scholar
  4. 4.
    Gvozdjáková A (2006) Asthma, corticosteroids and coenzyme Q10. http://www.vitasearch.com/get/PC/experts/AGvozdjakovaAT10–02-06.htm
  5. 5.
    Kinulla V (2005) Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy 4(4):465–470CrossRefGoogle Scholar

References

  1. 1.
    Cadenas E, Packer L (1996) (eds) Handbook of Antioxidants. Marcel Dekker, NY, pp 545–591Google Scholar
  2. 2.
    Foster TS (2007) Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomathic diabetic neuropathy. Diabetes Educa 33(1):111–117CrossRefGoogle Scholar
  3. 3.
    Gvozdjáková A, Palacka P, Kucharská J, Okkelová A, Murín J (2007) Beneficial effect of simultaneous coenzyme Q10 and -lipoic acid supplementation in patients with diabetic cardiomyopathy. Fifth Conference of the International Coenzyme Q 10 Association, Kobe, Japan, November 9–12, 2007, No. JP-051Google Scholar
  4. 4.
    Murray MT (1996) Encyclopedia of Nutritional Supplements. Prima Publishing, Rocklin, CA, pp 243–346Google Scholar
  5. 5.
    Packer L, Tritschler HJ, Wesssel K (1997) Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 22(1–2):359–378PubMedCrossRefGoogle Scholar
  6. 6.
    Reljanivic M, Reichel C et al. (1999) Treatment of diabetic peripheral neuropathy with the antioxidant thioctic acid (alpha-lipoic acid). A two tier multicenter randomized double-blind placebo-controlled trial (ALADIN II). Free Radic Res 31:171–179CrossRefGoogle Scholar
  7. 7.
    Ziegler D, Hanefeld M et al. (1995) Treatment of symtomatic diabetic peripheral neuropathy with antioxidant alpha-lipoic acid. A 3-week multicentral randomized controlled trial (ALADIN Study). Diabetologia 38:1425–1433PubMedCrossRefGoogle Scholar
  8. 8.
    Ziegler D, Hanefeld M et al. (1999) Treatment of symtomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid. A 7-month multicenter randomized controlled trial (ALADIN III Study). Diabetes Care 22:1296–1301PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media B.V 2008

Authors and Affiliations

  • Anna Gvozdjáková
    • Anna Hlavatá
      • 1
    • Jarmila Kucharská
      • 2
    • Patrik Palacka
      • 3
    • Ján Murín
      • 4
    1. 1.Second Pediatric ClinicComenius UniversitySlovakia
    2. 2.Pharmacobiochemical LaboratoryComenius UniversitySlovakia
    3. 3.National Cancer InstituteSlovakia
    4. 4.First Medical ClinicComenius UniversitySlovakia

    Personalised recommendations